CNBCAmgen takes 20% stake in Chinese biotech BeiGene for $2.7 billionOct 31, 2019Berkeley Lovelace & Berkeley Lovelace Jr.By Berkeley Lovelace & Berkeley Lovelace Jr.more_vert